SGLT2 inhibitors for HF treatments in 2022 - What do the guidelines tell us?
Session:
SGLT2 inhibitors in practice (part 1): what is the state of heart failure treatment in 2022?
Topic:
Chronic Heart Failure, Other
Speaker:
Professor G. Rosano (London, GB)
Sponsored by Boehringer Ingelheim & Eli Lilly
Event:
ESC Congress 2022
Congress Presentation
About the speaker
Professor Giuseppe Rosano
St Georges Medical School, London (United Kingdom of Great Britain & Northern Ireland)
100
presentations
23
followers
3 more presentations in this session
Access the full session
About the event
ESC 365 is supported by
